// App-Quantinova.ai

: ANGIOTENSIN II TYPE 1 RECEPTOR AUTOANTIBODIES ( CAUSE OR CONSEQUENCE OF HUMAN PRIMARY ALDOSTERONISM? )

Researchers

Presenter

  • Piazza, M

Principal Investigators

  • Seccia, T.M

  • Caroccia, B

  • Rossitto, G

  • Rossi, G.P

Medical Centers

  • University of Padue, Department of Medicine, Padua, ITALY

  • University of Glasgow, Immunology, Glasgow, UNITED KINGDOM

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Primary aldosteronism

Biomarkers

  • DNA Damage Inducible Transcript 3

  • Immunoglobulin G

Drug/Treatment

  • Angiotensin II

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A